Citation Impact
Citing Papers
Active learning increases student performance in science, engineering, and mathematics
2014 Standout
Tumor imaging by means of proteolytic activation of cell-penetrating peptides
2004 StandoutNobel
Electronic search strategies to identify reports of cluster randomized trials in MEDLINE: low precision will improve with adherence to reporting standards
2010
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
2008 StandoutNature
EGFR Antagonists in Cancer Treatment
2008 Standout
New Technology and Health Care Costs — The Case of Robot-Assisted Surgery
2010 Standout
CONSORT statement: extension to cluster randomised trials
2004 Standout
Evaluation of Cluster Randomized Controlled Trials in Sub-Saharan Africa
2003
Tumor detection using 18F-labeled matrix metalloproteinase-2 inhibitor
2003
IDH1andIDH2Mutations in Gliomas
2009 Standout
Accounting for cluster randomization: a review of primary prevention trials, 1990 through 1993.
1995
Gene Therapy-Mediated Reprogramming Tumor Infiltrating T Cells Using IL-2 and Inhibiting NF-κB Signaling Improves the Efficacy of Immunotherapy in a Brain Cancer Model
2012 StandoutNobel
Cluster randomised trials in the medical literature: two bibliometric surveys
2004
Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial
2006 Standout
Bone and cancer: Pathophysiology and treatment of metastases
1995
Calcium's Role in Mechanotransduction during Muscle Development
2014 Standout
Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?
1998 Standout
A painful peripheral neuropathy in the rat produced by the chemotherapeutic drug, paclitaxel
2001 Standout
Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease
2002 Standout
Development of Matrix Metalloproteinase Inhibitors in Cancer Therapy
2001
Issues in the meta‐analysis of cluster randomized trials
2002
Essential Role of TRPC6 Channels in G2/M Phase Transition and Development of Human Glioma
2010
Radiotherapy for Glioblastoma in the Elderly
2007
Impact of therapy on quality of life, neurocognitive function and their correlates in glioblastoma multiforme: a review
2011
Early Palliative Care for Patients with Metastatic Non–Small-Cell Lung Cancer
2010 Standout
Evaluation of cluster‐randomized trials on maternal and child health research in developing countries
2009
Inhibition of angiogenesis and invasion in malignant gliomas
2007
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
2016 Standout
Consort 2010 statement: extension to cluster randomised trials
2012 Standout
Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
2014 Standout
Advances in Brain Tumor Surgery
2007
Effectiveness of Specialized Palliative Care
2008
Population-Based Studies on Incidence, Survival Rates, and Genetic Alterations in Astrocytic and Oligodendroglial Gliomas
2005
Temozolomide as an alternative to irradiation for elderly patients with newly diagnosed malignant gliomas
2003
Lifetime risk of dementia and Alzheimer's disease
1997
Development of a gene/drug dual delivery system for brain tumor therapy: Potent inhibition via RNA interference and synergistic effects
2013
The benefits of being present: Mindfulness and its role in psychological well-being.
2003 Standout
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
2010 Standout
Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain
2006
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis
1999 StandoutNature
Targeted Molecular Therapy of GBM
2003
Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement
1999 Standout
Patterns of intra-cluster correlation from primary care research to inform study design and analysis
2004
Intraclass correlation coefficients for cluster randomized trials in primary care
2002
Malignant Gliomas in Adults
2008 Standout
Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials
1995 Standout
The methodological quality of cluster randomised controlled trials for managing tropical parasitic disease: a review of trials published from 1998 to 2007
2009
Rapid vascular regrowth in tumors after reversal of VEGF inhibition
2006
Improving the quality of reporting of randomized controlled trials. The CONSORT statement
1996 Standout
Synthesis and preliminary biological evaluation of MMP inhibitor radiotracers [11C]methyl-halo-CGS 27023A analogs, new potential PET breast cancer imaging agents
2002
Factors associated with acceptance and full publication of GI endoscopic research originally published in abstract form
2001
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
2005 Standout
Optical Imaging of Matrix Metalloproteinase–2 Activity in Tumors: Feasibility Study in a Mouse Model
2001
Primary brain tumours in adults
2012 Standout
Design and Analysis of Group-Randomized Trials in Cancer: A Review of Current Practices
2008
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies
2007 Standout
Endometriosis
2004 Standout
A critical analysis of the accuracy, reproducibility, and clinical utility of histologic endometrial dating in fertile women
2004
Mechanisms of Bone Metastasis
2004 Standout
Selective Blockade of the Capsaicin Receptor TRPV1 Attenuates Bone Cancer Pain
2005 StandoutNobel
Impact of CONSORT extension for cluster randomised trials on quality of reporting and study methodology: review of random sample of 300 trials, 2000-8
2011
Identification of human brain tumour initiating cells
2004 StandoutNature
Cluster randomized trials of cancer screening interventions: Are appropriate statistical methods being used?
2011
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
2007 Standout
Molecular mechanisms and clinical applications of angiogenesis
2011 StandoutNature
High-grade malignant glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010
Tumor Angiogenesis
2008 Standout
The role of matrix metalloproteinases in the pathophysiology and progression of human nervous system malignancies: a chance for the development of targeted therapeutic approaches?
2008
Internal and external validity of cluster randomised trials: systematic review of recent trials
2008
Brain Tumors
2001 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Beyond CONSORT: Need for Improved Reporting Standards for Clinical Trials
1998
Iron-Catalyzed Reactions in Organic Synthesis
2004 Standout
Matrix Metalloproteinases: Biologic Activity and Clinical Implications
2000
Advanced Statistics:Statistical Methods for Analyzing Cluster and Cluster‐randomized Data
2002
Electrospinning and Electrospun Nanofibers: Methods, Materials, and Applications
2019 Standout
Chemotherapy‐induced peripheral neurotoxicity: A critical analysis
2013
Considering clustering: a methodological review of clinical decision support system studies.
2000
Angiopoietin-2 induces human glioma invasion through the activation of matrix metalloprotease-2
2003
A Prospective Study of Quality of Life in Adults with Newly Diagnosed High-grade Gliomas: The Impact of the Extent of Resection on Quality of Life and Survival
2005
New Strategies for Fluorescent Probe Design in Medical Diagnostic Imaging
2009 Standout
Design and Analysis of Group-Randomized Trials: A Review of Recent Practices
2004
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials
2001 Standout
Full publication of results initially presented in abstracts
2007 Standout
Dual-Targeting Upconversion Nanoprobes across the Blood–Brain Barrier for Magnetic Resonance/Fluorescence Imaging of Intracranial Glioblastoma
2014
Metastatic bone disease: clinical features, pathophysiology and treatment strategies
2001 Standout
Systematic Review: Comparative Effectiveness and Harms of Treatments for Clinically Localized Prostate Cancer
2008
Partner Understanding of the Breast and Prostate Cancer Experience
2001
Upconversion Luminescent Materials: Advances and Applications
2014 Standout
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations
2002 StandoutScience
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
2010 Standout
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies
2007 Standout
Genetic Pathways to Glioblastoma
2004
Methylation of hypoxia-inducible factor (HIF)-1α by G9a/GLP inhibits HIF-1 transcriptional activity and cell migration
2018 StandoutNobel
The Effects of High Stakes High School Achievement Awards: Evidence from a Randomized Trial
2009 StandoutNobel
CMAJ endorses the CONSORT statement. CONsolidation of Standards for Reporting Trials.
1996
Design and Therapeutic Application of Matrix Metalloproteinase Inhibitors
1999
Synthesis of radiolabeled biphenylsulfonamide matrix metalloproteinase inhibitors as new potential PET cancer imaging agents
2003
A Proposal for Structured Reporting of Randomized Controlled Trials
1994
CE TEST: The Menopausal Symptom Experience in Young Mid-life Women With Breast Cancer.
2001
Works of Penny Brasher being referenced
Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas
1999
A randomized, controlled trial of intravenous clodronate in patients with metastatic bone disease and pain
1997
Prospective study of postoperative magnetic resonance imaging in patients with malignant gliomas.
1997
A randomized controlled trial of a brief psychoeducational support group for partners of early stage breast cancer patients
2000
A Methodological Review of Non-Therapeutic Intervention Trials Employing Cluster Randomization, 1979–1989
1990
Malignant supratentorial glioma in the elderly
1996
Prospective study of paclitaxel-induced peripheral neuropathy with quantitative sensory testing
1997
High levels of gelatinase-B and active gelatinase-A in metastatic glioblastoma
1998
Reovirus as an Oncolytic Agent Against Experimental Human Malignant Gliomas
2001
Prospective trial of cryosurgical ablation of the prostate: five-year results
2002
Long-term Glioblastoma Multiforme Survivors: a Population-based Study
1998
A double-blind, crossover trial of intravenous clodronate in metastatic bone pain
1992
Marked inhibition of tumor growth in a malignant glioma tumor model by a novel synthetic matrix metalloproteinase inhibitor AG3340.
1999
Efficacy and Safety Evaluation of Human Reovirus Type 3 in Immunocompetent Animals
2004
Acceptance by the aga is the single best indicator of subsequent full publication of research
1998
How often are nonenhancing supratentorial gliomas malignant? A population study
2002
Which glioblastoma multiforme patient will become a long-term survivor? A population-based study
1999
The accuracy and interobserver reproducibility of endometrial dating
2001
Risks and probabilities of breast cancer: short-term versus lifetime probabilities.
1994
Abbreviated Course of Radiation Therapy in Older Patients With Glioblastoma Multiforme: A Prospective Randomized Clinical Trial
2004